AFC-TAB-008

C5 antibody from Creative Biolabs
C5a, C5b, CPAMD4
ELISA
Recommended by provider
Immunocytochemistry
Recommended by provider
Immunoprecipitation
Recommended by provider
Flow cytometry
Recommended by provider
Blocking/Neutralizing
Recommended by provider
Functional assay
Recommended by provider

Antibody data

Product number
AFC-TAB-008
Provider
Creative Biolabs
Product name
Afuco? Anti-C5 ADCC Therapeutic Antibody (Eculizumab), ADCC Enhanced
Provider product page
Creative Biolabs - AFC-TAB-008
Antibody type
Monoclonal
Description
This product is an ADCC enhanced antibody produced by our Afuco? platform. Recombinant monoclonal antibody to Human C5. Eculizumab also is the first agent approved for the treatment of atypical hemolytic uremic syndrome (aHUS), an ultra-rare genetic disease that causes abnormal blood clots to form in small blood vessels throughout the body, leading to kidney failure, damage to other vital organs and premature death.
Reactivity
Human
Host
Human
Conjugate
Unconjugated
Isotype
IgG
Antibody clone number
Eculizumab
Storage
Store at +4¡«C short term (1-2 weeks). Aliquot and store at -20¡«C long term. Avoid repeated freeze/thaw cycles.
Provider Type Product Number
- No reagents -